Reddy P, Peterkofsky A, McKenney K
Laboratory of Biochemical Genetics, National Heart, Lung and Blood Institute, Bethesda, MD 20892.
Nucleic Acids Res. 1989 Dec 25;17(24):10473-88. doi: 10.1093/nar/17.24.10473.
We describe the construction of a new generation of vectors (pRE) for the hyperexpression of lethal gene products such as adenylate cyclase in Escherichia coli. The pRE vectors are based on the lambda PL promoter and lambda cII ribosome binding site described by Shimatake and Rosenberg (Nature, 292, 128-132, 1981). They have a unique NdeI restriction endonuclease site 3' of the lambda cII ribosome binding site that includes the ATG initiation codon, multilinker cloning sites 3' to the NdeI site, and two lambda transcription terminators 5' and 3' of the lambda PL promoter to eliminate nonspecific transcription and reduce leaky PL transcription, respectively. For hyperexpression of adenylate cyclase, tight control of transcription was necessary since elevation of cAMP levels above the physiological range is lethal to E. coli. Lethality associated with the overproduction of adenylate cyclase was shown to be mediated through the cAMP receptor protein. We used this expression system to overproduce adenylate cyclase 7500 fold, corresponding to 30% of the total cellular protein. Under these conditions the enzyme precipitated with significant loss of activity. Reducing the rate and amount of adenylate cyclase expression to 16% of the total cell protein produced one fourth of the enzyme in a soluble form with high specific activity. The soluble adenylate cyclase was purified to near homogeneity.
我们描述了用于在大肠杆菌中超量表达诸如腺苷酸环化酶等致死性基因产物的新一代载体(pRE)的构建。pRE载体基于Shimatake和Rosenberg(《自然》,292卷,128 - 132页,1981年)所描述的λPL启动子和λcII核糖体结合位点。它们在λcII核糖体结合位点下游3'处有一个独特的NdeI限制性核酸内切酶位点,该位点包含ATG起始密码子,在NdeI位点下游有多个多克隆位点,并且在λPL启动子的5'和3'端分别有两个λ转录终止子,以消除非特异性转录并分别减少PL的渗漏转录。对于腺苷酸环化酶的超量表达,转录的严格控制是必要的,因为将cAMP水平提高到生理范围以上对大肠杆菌是致死的。与腺苷酸环化酶过量产生相关的致死性被证明是通过cAMP受体蛋白介导的。我们使用这个表达系统将腺苷酸环化酶超量表达了7500倍,相当于总细胞蛋白的30%。在这些条件下,该酶沉淀且活性显著丧失。将腺苷酸环化酶的表达速率和量降低到总细胞蛋白的16%,产生了四分之一的具有高比活性的可溶性形式的酶。可溶性腺苷酸环化酶被纯化至接近均一。